Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4786728 | 5897279 | I | 4786728-2 | 20050915 | 20050930 | EXP | 12409 | MAYNE PHARMA PTY LTD. | 19 | MON | N | 20050930 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4786728 | 1006478232 | PS | VINCRISTINE | 1 | 1.5 MG/M2 PER_CYCLE | D | D | 71484 | |||
| 4786728 | 1006500325 | SS | CYCLOPHOSPHAMIDE | 1 | 2200 MG/M2 PER_CYCLE | D | D | ||||
| 4786728 | 1006500327 | SS | DACTINOMYCIN | 1 | 1.5 MG/M2 PER_CYCLE | D | D |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4786728 | 1006478232 | RHABDOMYOSARCOMA |
| 4786728 | 1006500325 | RHABDOMYOSARCOMA |
| 4786728 | 1006500327 | RHABDOMYOSARCOMA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4786728 | DE |
| 4786728 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4786728 | VENOOCCLUSIVE LIVER DISEASE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4786728 | HP |
| 4786728 | LIT |
Therapies reported
| no results found |